[1]
“ANTITUMOR CHEMOTHERAPY IN COMBINED TREATMENT OF PATIENTS WITH CANCER OF THE LARYNX AND HYPOPHARYNX”, Вопр. онкол., vol. 64, no. 5, pp. 607–611, May 2018, doi: 10.37469/0507-3758-2018-64-5-607-611.